Latest Breaking News On - Hepatocellular carcinoma - Page 2 : comparemela.com

Median Technologies Reports Full-year 2023 Financial Results and Provides First Quarter 2024 Financial Information

Median Technologies Reports Full-year 2023 Financial Results and Provides First Quarter 2024 Financial Information
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesFrance generalLcs cade cadxCaroline carmagnolEmmanuelle leyguesGhislaine gasparettoDrug administrationCompany board of directors onEuropean investment bankImaging labHead of corporate marketing financial communicationsImaging lab is medianContract research organizationChinese national medical products administrationImaging contract research organizationEuropean society of medical oncology

Dr Amit Singal on Populations at Risk for HCC and When Screening Is Needed

Amit Singal, MD, medical director of the UT Southwestern Medical Center Liver Tumor Program, discusses populations at the highest risk of hepatocellular carcinoma (HCC), when screening is needed, and key tools in HCC surveillance and screening.

Ramit singalBen franklinLiver tumor programUt southwestern medical centerMedical centerHepatocellular carcinomaLiver cancerLiver cancer screening

Study identifies molecular pathway in liver cancer development

As a malignant disease of the liver cells, hepatocellular carcinoma (HCC) is one of the main causes of cancer-related deaths.

Erwin wagnerLatifa bakiriProceedings of the national academy sciencesMeduni vienna clinical institute for laboratory medicineUniversity of viennaMeduni viennaClinical instituteLaboratory medicineNational academyLiver cancerHepatocellular carcinomaTranscription factors

How liver transplant can save the lives of those suffering from liver diseases

If you have severe and chronic liver diseases such as liver cirrhosis or liver cancer, a liver transplant can be life-saving for you

Gaurav chaubalGleneagles hospitalsHepatocellular carcinomaAcute liver failureWhatsapp channelsLiver transplantLiver diseasesDive conditionsLiver cancerFatty liver diseaseChronic liver diseaseLiver transplantationPublic healthEalth and wellnessHealth issues

Health Canada Green Lights Subcutaneous Atezolizumab for Lung, Breast, and Liver Cancer

Health Canada has approved subcutaneous atezolizumab for use in patients with lung cancer, breast cancer, and hepatocellular carcinoma.

Michelle formanSara mooreHealth canadaBurnaby hospital cancer centreEuropean commissionOttawa hospitalSubcutaneous atezolizumabHepatocellular carcinoma